Tower Research Capital (TRC)’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,302
| Closed | -$37.7K | – | 6307 |
|
|
2023
Q4 | $37.7K | Buy |
9,302
+3,568
| +62% | +$14.5K | ﹤0.01% | 3305 |
|
|
2023
Q3 | $15.4K | Buy |
5,734
+5,036
| +721% | +$13.5K | ﹤0.01% | 3617 |
|
|
2023
Q2 | $6.51K | Sell |
698
-720
| -51% | -$6.72K | ﹤0.01% | 4669 |
|
|
2023
Q1 | $13K | Sell |
1,418
-3,732
| -72% | -$34.2K | ﹤0.01% | 4033 |
|
|
2022
Q4 | $26K | Buy |
5,150
+730
| +17% | +$3.69K | ﹤0.01% | 2901 |
|
|
2022
Q3 | $26K | Buy |
4,420
+1,757
| +66% | +$10.3K | ﹤0.01% | 3735 |
|
|
2022
Q2 | $15K | Buy |
2,663
+1,255
| +89% | +$7.07K | ﹤0.01% | 4109 |
|
|
2022
Q1 | $16K | Sell |
1,408
-712
| -34% | -$8.09K | ﹤0.01% | 3777 |
|
|
2021
Q4 | $27K | Buy |
+2,120
| New | +$27K | ﹤0.01% | 3364 |
|